Caffeine-potentiated chemotherapy for metastatic carcinoma and lymphoma of bone and soft tissue

Anticancer Research

Volumn 25, Issue 3 C, 2005, Pages 2399-2405

  Hayashi, Masayuki ^a   Tsuchiya, Hiroyuki ^a   Yamamoto, Norio ^a   Karita, Michiaki ^a   Shirai, Toshiharu ^a   Nishida, Hideji ^a   Takeuchi, Akihiko ^a   Tomita, Katsuro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Caffeine; Chemotherapy; Metastatic tumor; Musculoskeletal sarcoma

Indexed keywords

CAFFEINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LYMPHOMA; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SOFT TISSUE CANCER; STOMACH CANCER; TUMOR NECROSIS; VAGINA CARCINOMA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BREAST NEOPLASMS; CAFFEINE; CARCINOMA; DRUG SYNERGISM; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; SOFT TISSUE NEOPLASMS; STOMACH NEOPLASMS; VAGINAL NEOPLASMS;

EID: 22944448045     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tsuchiya H, Yasutake H, Yokogawa A et al: Effect of chemotherapy combined with caffeine for osteosarcoma. J Cancer Res Clin Oncol 118: 567-569, 1992.
2. Tsuchiya H, Tomita K, Mori Y et al: Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 18: 657-666, 1998.
3. Tsuchiya H, Tomita K, Yamamoto N et al: Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Anticancer Res 18: 3651-3656, 1998.
4. Tsuchiya H, Tomita K, Mori Y et al: Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop 358: 27-35, 1999.
5. Tsuchiya H, Yamamoto N, Asada N et al: Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft-tissue sarcoma. Anticancer Res 20: 2137-2144, 2000.
6. Therasse P, Arbuck SG and Eisenhauer EA: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
7. Tsuchiya H, Wann SL, Yamamoto N et al: Reconstruction using an autograft containing tumor treated by liquid nitrogen. J Bone Joint Surg Br 87: 218-225, 2005.
8. Byfield JE, Murnane J, Ward JF et al: Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumors to alkylating agents. Br J Cancer 43: 669-683, 1981.
9. Van Den Berg HW and Roberts JJ: Inhibition by caffeine of post-replication repair in Chinese hamster cells treated with cis platinum (II) diamminedichloride: the extent of platinum binding to template DNA in relation to the size of low molecular weight nascent DNA. Chem Biol Interact 12: 375-390, 1976.
10. Tomita K and Tsuchiya H: Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 80: 83-88, 1989.
11. Tomita K and Tsuchiya H: Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma. Clin Ther 11: 43-52, 1989.
12. Yasutake H, Tsuchiya H, Tomita K et al: Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated human osteosarcoma cells. Anticancer Res 15: 831-837, 1995.
13. Boike GM, Petru E, Sevin BU et al: Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line. Gynecol Oncol 38: 315-322, 1990.
14. Gude RP, Menon LG and Rao SG: Effect of caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. J Exp Clin Cancer Res 20: 287-292, 2001.
15. Kyriazis AP, Kyriazis AA and Yagoda A: Enhanced therapeutic effect of cis-diamminedichloroplatinum (II) against nude mouse grown human pancreatic adenocarcinoma when combined with 1-beta-D-arabinofuranosylcytosine and caffeine. Cancer Res 45: 6083-6087, 1985.
16. Janss AJ, Levow C, Bernhard EJ et al: Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell lines. Exp Cell Res 243: 29-38, 1998.
17. Ogasawara H, Nishio K, Ishida T et al: In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells. Jpn J Cancer Res 88: 1033-1037, 1997.
18. Takahashi M, Yanoma S, Yamamoto Y et al: Combined effect of CDDP and caffeine against human gastric cell line in vivo. Anticancer Res 18: 4399-4401, 1998.
19. Tsai CM, Perng RP, Chen MH et al: Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines. J Natl Cancer Inst 86: 1018-1020, 1994.
20. Cohen M, Schoenfeld D and Wolter J: Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma. Cancer Treat Rep 64: 151-153, 1980.
21. Stewart DJ, Benoit B, Hugenholtz H et al: Cisplatin, arabinofuranosylcytosine and caffeine before radiation for glioblastomas. In: Biology of Brain Tumors (ed. 1) (Walker MD, Thomas DT, eds). Boston, Martinus Nijhoff, pp. 393-398, 1986.
22. Al-Sukhun S, Zalupski MM, Ben-Josef E et al: Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study. Am J Clin Oncol 26: 543-549, 2003.
23. Kelsen D, Hudis C, Niedzwiecki D et al: A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma. Cancer 68: 965-969, 1991.